  See all
 |
Articles: Colorectal Cancer/Polyps |
Prior Articles
A Novel Polymorphism rs1329149 of CYP2E1 and a Known Polymorphism rs671 of ALDH2 of Alcohol Metabolizing Enzymes Are Associated with Colorectal Cancer in a Southwestern Chinese Population
Cancer Epidemiology, Biomarkers & Prevention, 09/14/09
Vitamin D Related Genes, CYP24A1 and CYP27B1, and Colon Cancer Risk
Cancer Epidemiology, Biomarkers & Prevention, 09/14/09 Genetic Variants in XRCC2: New Insights Into Colorectal Cancer Tumorigenesis
Cancer Epidemiology, Biomarkers & Prevention, 09/14/09 Amphiregulin and epiregulin mRNA expression in primary tumors predicts outcome in metastatic colorectal cancer treated with cetuximab
Journal of Clinical Oncology, 09/11/09 Incidence of cancer and statin usage
International Journal of Cancer, 09/11/09 Adjuvant chemotherapy for stages II, III and IV of colon cancer
Clinical and Translational Oncology, 09/11/09 Perineural invasion is an independent predictor of outcome in colorectal cancer
Journal of Clinical Oncology, 09/10/09 Phase II, randomized, double-blind, placebo-controlled study of recombinant human intestinal trefoil factor oral spray for prevention of oral mucositis in patients with colorectal cancer who are receiving fluorouracil-based chemotherapy
Journal of Clinical Oncology, 09/10/09 Clinical outcome of elderly patients with metastatic colorectal cancer treated with FOLFOXIRI versus FOLFIRI: Subgroup analysis of a randomized phase III trial from the Hellenic Oncology Research Group (HORG)
Critical Reviews in Oncology/Hematology, 09/10/09 Familial colorectal cancer, can it be identified by microsatellite instability and chromosomal instability? – A case-control study
Cancer Biomarkers, 09/10/09 K-ras status in squamous cell anal carcinoma (SCC): its time for target-oriented treatment
Cancer Chemotherapy and Pharmacology, 09/10/09 Costs Associated with Capecitabine or 5-Fluorouracil Monotherapy after Surgical Resection in Patients with Colorectal Cancer
Oncology (Karger), 09/10/09 The Role of KRAS Mutations in Predicting the Efficacy of Cetuximab-Plus-Irinotecan Therapy in Irinotecan-Refractory Korean Metastatic Colorectal Cancer Patients
Oncology (Karger), 09/10/09 Products of the Colonic Microbiota Mediate the Effects of Diet on Colon Cancer Risk
The Journal of Nutrition, 09/10/09 Role of CA19.9 in predicting bevacizumab efficacy for metastatic colorectal cancer patients
Cancer Biomarkers, 09/09/09 Phase II study of S-1 combined with irinotecan (CPT-11) in patients with advanced colorectal cancer
Oncology (Karger), 09/08/09 Randomized clinical trial of preoperative intravenous iron sucrose to reduce blood transfusion in anaemic patients after colorectal cancer surgery
British Journal of Surgery, 09/08/09 Tissue Biomarker Development in a Multicentre Trial Context: a Feasibility Study on the PETACC3 Stage II and III Colon Cancer Adjuvant Treatment Trial
Clinical Cancer Research, 09/08/09 Tumor Cell-Microenvironment Interaction Models Coupled with Clinical Validation Reveal CCL2 and SNCG as Two Predictors of Colorectal Cancer Hepatic Metastasis
Clinical Cancer Research, 09/08/09 Differences in Repair of DNA Cross-links between Lymphocytes and Epithelial Tumor Cells from Colon Cancer Patients Measured In vitro with the Comet Assay
Clinical Cancer Research, 09/08/09
|
|
|
|
Indexed Journals: Journal of Clinical Oncology, Cancer Research, Annals Oncology
more...
|
250 Available Pages
|
|
